Consistent with this concept, our data demonstrated that naïve Treg-cells derived from FoxP3GFP mice do not express CCR6, while FoxP3GFP+ Treg-cells predominantly expressed high levels of CCR6 in tumor tissue 2 weeks after adoptive transfer into tumor bearing mice. The gene discussed is CCR6; the disease is neoplasm.